Raymond S.L. Chang

6.2k citations

114 papers · 4.7k indexed · 1 hit paper · h-index 31

Cellular and Molecular Neuroscience top 1%
- Neuropeptides and Animal Physiology 41
Organic Chemistry top 1%
- Synthesis and Biological Evaluation 15
- Quinazolinone synthesis and applications 13
Molecular Biology top 2%
- Receptor Mechanisms and Signaling 52
- Chemical Synthesis and Analysis 14
Toxicology top 2%
Pharmacology top 2%
Cardiology and Cardiovascular Medicine
- Renin-Angiotensin System Studies 25
Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 12
Oncology
- Peptidase Inhibition and Analysis 8

Co-authors: Victor J. Lotti Solomon H. Snyder Vinh T. Tran Paul J. Kling Roger Freidinger Mark G. Bock Deborah J. Cerino Robert M. DiPardo
Cited by: Cellular and Molecular Neuroscience Organic Chemistry Molecular Biology
Journals: Journal of the American Chemical Society (1 paper)Circulation (1 paper)Brain Research (1 paper)
Partner nations: United States Japan United Kingdom

In The Last Decade

Raymond S.L. Chang

114 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Raymond S.L. Chang

Since Specialization

Citations

This map shows the geographic impact of Raymond S.L. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond S.L. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond S.L. Chang more than expected).

Fields of papers citing papers by Raymond S.L. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond S.L. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond S.L. Chang. The network helps show where Raymond S.L. Chang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raymond S.L. Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raymond S.L. Chang Line = papers co-authored together Raymond S.L. Chang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	2-Aminobenzophenones as a Novel Class of Bradykinin B₁Receptor Antagonists Journal of Medicinal Chemistry ·Dai‐Shi Su,John L. Lim,Elizabeth Tinney,Bang-Lin Wan,Kathy Murphy,Duane R. Reiss,C. Meacham Harrell,Stacy S. O’Malley,Rick W. Ransom,Raymond S.L. Chang,Douglas J. Pettibone,Jian Yu,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Mark G. Bock,Neville J. Anthony	2008	13
2	Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides ChemMedChem ·Craig W. Lindsley,Zhijian Zhao,William Leister,Julie L. O'Brien,Wei Lemaire,David L. Williams,Tsing‐Bau Chen,Raymond S.L. Chang,Maryann Burno,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,Douglas J. Pettibone,Philip R. Tiller,Sheri Smith,Nancy N. Tsou,Mark E. Duggan,P. Jeffrey Conn,George D. Hartman	2006	32
3	Generation and Characterization of a Human Bradykinin Receptor B1 Transgenic Rat as a Pharmacodynamic Model Journal of Pharmacology and Experimental Therapeutics ·J. Fred Hess,Richard W. Ransom,Zhizhen Zeng,Raymond S.L. Chang,Patricia J. Hey,Lee Warren,C. Meacham Harrell,Kathryn L. Murphy,Tsing‐Bau Chen,Patricia Miller,Edward V. Lis,Duane R. Reiss,Raymond E. Gibson,M. Kristine Markowitz,Robert M. DiPardo,Dai‐Shi Su,Mark G. Bock,Robert J. Gould,Douglas J. Pettibone	2004	19
4	A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 Molecular Pharmacology ·Julie A. O’Brien,Wei Lemaire,Tsing‐Bau Chen,Raymond S.L. Chang,Marlene A. Jacobson,Sookhee Ha,Craig W. Lindsley,Hervé Schaffhauser,Cyrille Sur,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	2003	170
5	Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective α1a-receptor antagonists Bioorganic & Medicinal Chemistry Letters ·James C. Barrow,Kristen L. Glass,Harold G. Selnick,Roger Freidinger,Raymond S.L. Chang,Stacey O’Malley,Carla J. Woyden	2000	20
6	Selective α1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones Bioorganic & Medicinal Chemistry Letters ·Philippe G. Nantermet,James C. Barrow,Harold G. Selnick,Carl F. Homnick,Roger Freidinger,Raymond S.L. Chang,Stacey O’Malley,Duane R. Reiss,Theodore P. Broten,Richard W. Ransom,Douglas J. Pettibone,Timothy Olah,Carlos Forray	2000	44
7	Phenylacetamides as selective α-1A adrenergic receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Michael A. Patane,Robert M. DiPardo,Randall C. Newton,RoseAnn P. Price,Theodore P. Broten,Raymond S.L. Chang,Richard W. Ransom,Jerry Di Salvo,Dhanapalan Nagarathnam,Carlos Forray,Charles Gluchowski,Mark G. Bock	2000	8
8	In vitro studies on L-771,688 (SNAP 6383), a new potent and selective α1A-adrenoceptor antagonist European Journal of Pharmacology ·Raymond S.L. Chang,Tsing-Bau Chen,Stacey O’Malley,Douglas J. Pettibone,Jerry DiSalvo,Barbara Francis,Mark G. Bock,Roger Freidinger,Dhanapalan Nagarathnam,Shou W Miao,Quanrong Shen,Bharat Lagu,T. G. Murali Dhar,Sriram Tyagarajan,Mohammad R. Marzabadi,Wai C. Wong,Charles Gluchowski,Carlos Forray	2000	29
9	Characterization of the binding of [125I]L-735,286: A new nonpeptide angiotensin II AT1 receptor radioligand Life Sciences ·T.B. Chen,Nancy J. Brenner,Raymond E. Gibson,H. Donald Burns,Raymond S.L. Chang	1995	6
10	In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors European Journal of Pharmacology ·Salah D. Kivlighn,Gloria J. Zingaro,Robert A. Gabel,Theodore P. Broten,Raymond S.L. Chang,Debra L. Ondeyka,Nathan B. Mantlo,Raymond E. Gibson,William J. Greenlee,Peter K. S. Siegl	1995	3
11	A Highly Potent, Orally Active Imidazo[4,5-b]pyridine Biphenyl Acylsulfonamide (MK-996; L-159,282): A New AT1-Selective Angiotensin II Receptor Antagonist Journal of Medicinal Chemistry ·Prasun K. Chakravarty,Elizabeth M. Naylor,Anna Chen,Raymond S.L. Chang,Tsing‐Bau Chen,Kristie A. Faust,Victor J. Lotti,Salah D. Kivlighn,Robert W. Gable	1994	45
12	Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles Journal of Medicinal Chemistry ·Daljit S. Dhanoa,Scott W. Bagley,Raymond S.L. Chang,Victor J. Lotti,Tsing Bau Chen,Salah D. Kivlighn,Gloria J. Zingaro,Peter K. S. Siegl,Arthur A. Patchett,William J. Greenlee	1993	24
13	Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles Journal of Medicinal Chemistry ·Wallace T. Ashton,Christine L. Cantone,Linda Chang,Steven M. Hutchins,Robert A. Strelitz,Malcolm MacCoss,Raymond S.L. Chang,Victor J. Lotti,Kristie A. Faust	1993	40
14	Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones Journal of Medicinal Chemistry ·Linda Chang,Wallace T. Ashton,Kelly L. Flanagan,Robert A. Strelitz,Malcolm MacCoss,William J. Greenlee,Raymond S.L. Chang,Victor J. Lotti,Kristie A. Faust	1993	20
15	A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor Journal of Medicinal Chemistry ·Stephen E. de Laszlo,Carol S. Quagliato,William J. Greenlee,Arthur A. Patchett,Raymond S.L. Chang,Victor J. Lotti,Tsing Bau Chen,Stacey A. Scheck,Kristi A. Faust	1993	102
16	Novel glutamic acid-derived cholecystokinin receptor ligands Journal of Medicinal Chemistry ·Roger Freidinger,Willie L. Whitter,N. P. GOULD,M. K. HOLLOWAY,Raymond S.L. Chang,Victor J. Lotti	1990	18
17	A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260 European Journal of Pharmacology ·Victor J. Lotti,Raymond S.L. Chang	1989	347
18	Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactams Journal of Medicinal Chemistry ·William H. Parsons,Arthur A. Patchett,M. K. HOLLOWAY,Graham Smith,J. L. DAVIDSON,Victor J. Lotti,Raymond S.L. Chang	1989	19
19	Specific [3H]propionyl-neuropeptide Y (NPY) binding in rabbit aortic membranes: Comparisons with binding in rat brain and biological responses in rat vas deferens Biochemical and Biophysical Research Communications ·Raymond S.L. Chang,Victor J. Lotti,Tsing‐Bau Chen	1988	42
20	Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines Journal of Medicinal Chemistry ·Mark G. Bock,Robert M. DiPardo,B. Evans,Kenneth E. Rittle,Daniel F. Veber,Roger Freidinger,Raymond S.L. Chang,Victor J. Lotti	1988	16

About Raymond S.L. Chang

Raymond S.L. Chang is a scholar working on Cellular and Molecular Neuroscience, Genetics and Cardiology and Cardiovascular Medicine, having authored 114 papers that have together received 4.7k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (52 papers), Neuropeptides and Animal Physiology (41 papers), Renin-Angiotensin System Studies (25 papers), Synthesis and Biological Evaluation (15 papers), Chemical Synthesis and Analysis (14 papers), Quinazolinone synthesis and applications (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.6k citations), Organic Chemistry (1.6k citations) and Molecular Biology (2.7k citations). Raymond S.L. Chang has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Victor J. Lotti, Solomon H. Snyder, Vinh T. Tran, Paul J. Kling, Roger Freidinger, Mark G. Bock, Deborah J. Cerino, Robert M. DiPardo, Tsing‐Bau Chen and James P. Springer. Their work appears in journals such as Journal of the American Chemical Society, Circulation and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact